Sapiens International (SPNS) has had the highest return since January 1, 2025 by a US stock with a market cap of $100M+, returning 53,426.8%.
| ASSET | % RETURN |
|---|---|
Sapiens International (SPNS) | 53,426.82% |
Regencell Bioscience (RGC) | 15,738.32% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,865.61% |
Diginex Limited Ordinary Shares (DGNX) | 1,148.83% |
NovaBay Pharmaceuticals (NBY) | 1,143.59% |
Oncology Institute (TOI) | 1,089.54% |
Hycroft Mining (HYMC) | 1,006.64% |
Zepp Health (ZEPP) | 987.31% |
Palvella Therapeutics (PVLA) | 790.35% |
Relmada Therapeutics (RLMD) | 769.31% |
DeFi Development (DFDV) | 756% |
Cidara Therapeutics (CDTX) | 714.46% |
Celcuity LLC (CELC) | 673.45% |
Avino Silver & Gold Mines (ASM) | 656.04% |
Nanobiotix (NBTX) | 640.84% |
Terns Pharmaceuticals (TERN) | 636.17% |
Sandisk (SNDK) | 613.21% |
AXT (AXTI) | 592.34% |
Newegg Commerce (NEGG) | 562.25% |
Almonty Industries Inc Common Shares (ALM) | 557.64% |
Americas Silver (USAS) | 550.53% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 536.88% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 524.72% |
TMC the metals (TMC) | 498.25% |
